Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71776 - 71800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NAALAD2	10003	upregulated	Silicon Dioxide results in increased expression of NAALAD2 mRNA	11q14.3	A24196
Silicon dioxide	Approved	NABP1	64859	upregulated	Silicon Dioxide analog results in increased expression of NABP1 mRNA	2q32.3	A24195
Silicon dioxide	Approved	NACC2	138151	upregulated	Silicon Dioxide analog results in increased expression of NACC2 mRNA	9q34.3	A24195
Silicon dioxide	Approved	NAP1L2	4674	upregulated	Silicon Dioxide analog results in increased expression of NAP1L2 mRNA	Xq13.2	A24194
Silicon dioxide	Approved	NAP1L3	4675	upregulated	Silicon Dioxide analog results in increased expression of NAP1L3 mRNA	Xq21.32	A24194
Silicon dioxide	Approved	NAPA	8775	downregulated	Silicon Dioxide analog results in decreased expression of NAPA mRNA	19q13.33	A24195
Silicon dioxide	Approved	NAT8L	339983	upregulated	Silicon Dioxide analog results in increased expression of NAT8L mRNA	4p16.3	A24195
Silicon dioxide	Approved	NAV1	89796	downregulated	Silicon Dioxide analog results in decreased expression of NAV1 mRNA	1q32.1	A24195
Silicon dioxide	Approved	NAV2	89797	downregulated	Silicon Dioxide analog results in decreased expression of NAV2 mRNA	11p15.1	A24195
Silicon dioxide	Approved	NAV2	89797	downregulated	Silicon Dioxide results in decreased expression of NAV2 mRNA	11p15.1	A24196
Silicon dioxide	Approved	NAV3	89795	upregulated	Silicon Dioxide analog results in increased expression of NAV3 mRNA	12q21.2	A24195
Silicon dioxide	Approved	NAV3	89795	upregulated	Silicon Dioxide results in increased expression of NAV3 mRNA	12q21.2	A24196
Silicon dioxide	Approved	NAXD	55739	downregulated	Silicon Dioxide results in decreased expression of NAXD mRNA	13q34	A24196
Silicon dioxide	Approved	NBEA	26960	downregulated	Silicon Dioxide analog results in decreased expression of NBEA mRNA	13q13.3	A24195
Silicon dioxide	Approved	NBEA	26960	upregulated	Silicon Dioxide results in increased expression of NBEA mRNA	13q13.3	A24196
Silicon dioxide	Approved	NBPF10	100132406	downregulated	Silicon Dioxide results in decreased expression of NBPF10 mRNA	1q21.1	A24196
Silicon dioxide	Approved	NCALD	83988	downregulated	Silicon Dioxide analog results in decreased expression of NCALD mRNA	8q22.3	A24195
Silicon dioxide	Approved	NCAPG	64151	downregulated	Silicon Dioxide analog results in decreased expression of NCAPG mRNA	4p15.31	A24194
Silicon dioxide	Approved	NCKAP5	344148	downregulated	Silicon Dioxide analog results in decreased expression of NCKAP5 mRNA	2q21.2	A24195
Silicon dioxide	Approved	NDRG2	57447	upregulated	Silicon Dioxide results in increased expression of NDRG2 mRNA	14q11.2	A24196
Silicon dioxide	Approved	NDRG4	65009	upregulated	Silicon Dioxide results in increased expression of NDRG4 mRNA	16q21	A24196
Silicon dioxide	Approved	NDST4	64579	downregulated	Silicon Dioxide analog results in decreased expression of NDST4 mRNA	4q26	A24195
Silicon dioxide	Approved	NDUFAF4	29078	upregulated	Silicon Dioxide analog results in increased expression of NDUFAF4 mRNA	6q16.1	A24195
Silicon dioxide	Approved	NDUFB2-AS1	100134713	downregulated	Silicon Dioxide results in decreased expression of NDUFB2-AS1 mRNA	7q34	A24196
Silicon dioxide	Approved	NEB	4703	downregulated	Silicon Dioxide analog results in decreased expression of NEB mRNA	2q23.3	A24195

Displaying entries 71776 - 71800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability